135 related articles for article (PubMed ID: 6749206)
1. Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
Balow JE; Austin HA; Muenz LR; Joyce KM; Antonovych TT; Klippel JH; Steinberg AD; Plotz PH; Decker JL
N Engl J Med; 1984 Aug; 311(8):491-5. PubMed ID: 6749206
[TBL] [Abstract][Full Text] [Related]
2. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
[TBL] [Abstract][Full Text] [Related]
3. Grand rounds: the treatment of lupus nephritis.
Hayslett JP
Va Med; 1979 May; 106(5):379-82. PubMed ID: 463254
[No Abstract] [Full Text] [Related]
4. Cytotoxic-drug treatment of lupus nephritis.
Donadio JV
N Engl J Med; 1984 Aug; 311(8):528-9. PubMed ID: 6749210
[No Abstract] [Full Text] [Related]
5. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of nephritis following disseminated lupus erythematosus with prednisone, azathioprine and cyclophosphamide].
Michielsen J; Go IH
Ned Tijdschr Geneeskd; 1974 Sep; 118(37):1403-5. PubMed ID: 4606008
[No Abstract] [Full Text] [Related]
7. Cytotoxic drug treatment of lupus nephritis.
Donadio JV; Holley KE; Ilstrup DM
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
9. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
10. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study.
Foster BJ; Bernard C; Drummond KN; Sharma AK
J Pediatr; 2000 Mar; 136(3):370-5. PubMed ID: 10700695
[TBL] [Abstract][Full Text] [Related]
11. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
12. Serial renal biopsy in systemic lupus erythematosus.
Bajaj S; Albert L; Gladman DD; Urowitz MB; Hallett DC; Ritchie S
J Rheumatol; 2000 Dec; 27(12):2822-6. PubMed ID: 11128670
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of diffuse proliferative lupus nephritis.
Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
[TBL] [Abstract][Full Text] [Related]
14. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
15. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
16. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
Felson DT; Anderson J
N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
[TBL] [Abstract][Full Text] [Related]
18. Treatment of lupus nephritis.
Kaplan D; Ginzler E
Proc Clin Dial Transplant Forum; 1974; (4):86-9. PubMed ID: 4468428
[No Abstract] [Full Text] [Related]
19. Progression from minimal or focal to diffuse proliferative lupus nephritis.
Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
